Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 4, 2015, Pages 723-733

  Valença, Isabel ^a   Pértega Gomes, Nelma ^b,c   Vizcaino, José Rámon ^d   Henrique, Rui M ^e,f   Lopes, Carlos ^d   Baltazar, Fátima ^b,c   Ribeiro, Daniela ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d Centro Hospitalar Universitario do Porto   (Portugal)

^e PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^f UNIVERSITY OF PORTO   (Portugal)

Author keywords

MCT2; Peroxisomes; Prostate cancer

Indexed keywords

BSG PROTEIN, HUMAN; CD147 ANTIGEN; ISOPROTEIN; MEMBRANE PROTEIN; MONOCARBOXYLATE TRANSPORTER; PEX14 PROTEIN, HUMAN; PEX19 PROTEIN, HUMAN; PROTEIN BINDING; REPRESSOR PROTEIN; SLC16A7 PROTEIN, HUMAN;

CELL LINE; CELL MEMBRANE; CELL NUCLEUS; CELL TRANSFORMATION; CONFOCAL MICROSCOPY; CYTOLOGY; CYTOPLASM; HUMAN; MALE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PEROXISOME; PROSTATE; PROSTATE TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIGENS, CD147; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; HUMANS; MALE; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MONOCARBOXYLIC ACID TRANSPORTERS; OXIDATION-REDUCTION; PEROXISOMES; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN ISOFORMS; REPRESSOR PROTEINS;

EID: 84925880705     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12481     Document Type: Article

References (30)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-74.
2. Sonveaux P, Végran F, Schroeder T, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clincal Investig. 2008; 118: 3930-42.
3. Feron O. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol. 2009; 92: 329-33.
4. Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, et al. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle. 2011; 10: 1772-83.
5. Pértega-Gomes N, Vizcaíno JR, Miranda-Gonçalves V, et al. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. BMC Cancer. 2011; 11: 312.
6. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Cllin. 2011; 61: 69-90.
7. Pértega-Gomes N, Vizcaíno JR, Gouveia C, et al. Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer. Prostate. 2013; 73: 763-9.
8. Pellerin L, Bergersen LH, Halestrap AP, et al. Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells and in the adult brain. J Neurosci Res. 2005; 79: 55-64.
9. Yoshida Y, Holloway GP, Ljubicic V, et al. Negligible direct lactate oxidation in subsarcolemmal and intermyofibrillar mitochondria obtained from red and white rat skeletal muscle. J Physiol. 2007; 582: 1317-35.
10. Benton CR, Campbell SE, Tonouchi M, et al. Monocarboxylate transporters in subsarcolemmal and intermyofibrillar mitochondria. Biochem Biophys Res Commun. 2004; 323: 249-53.
11. Mcclelland GB, Khanna S, Gonz GF, et al. Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system? Biochem Biophys Res Commun. 2003; 304: 130-5.
12. Lee I, Lee S, Kang WK, et al. Inhibition of monocarboxylate transporter 2 induces senescence-associated mitochondrial dysfunction and suppresses progression of colorectal malignancies in vivo. Mol Cancer Ther. 2012; 11: 2342-51.
13. Schmitz W, Albers C, Fingerhut R, et al. Purification and characterization of an a-methylacyl-CoA racemase from human liver. Eur J Biochem. 1995; 231: 815-22.
14. Amery L, Fransen M, De Nys K, et al. Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans. J Lipid Res. 2000; 41: 1752-9.
15. Ferdinandusse S, Denis S, IJlst L, et al. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res. 2000; 41: 1890-6.
16. Ferdinandusse S, van Grunsven EG, Oostheim W, et al. Reinvestigation of peroxisomal 3-ketoacyl-CoA thiolase deficiency: identification of the true defect at the level of d-bifunctional protein. Am J Hum Genet. 2002; 70: 1589-93.
17. Cuebas DA, Phillips C, Schmitz W, et al. The role of alpha-methylacyl-CoA racemase in bile acid synthesis. Biochem J. 2002; 363: 801-7.
18. Wanders RJ, Vreken P, Ferdinandusse S, et al. Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans. 2001; 29: 250-67.
19. Jones JM, Morrell JC, Gould SJ. PEX19 is a predominantly cytosolic chaperone and import receptor for class 1 peroxisomal membrane proteins. J Cell Biol. 2004; 164: 57-67.
20. Matsuzono Y, Matsuzaki T, Fujiki Y. Functional domain mapping of peroxin Pex19p: interaction with Pex3p is essential for function and translocation. J Cell Sci. 2006; 119: 3539-50.
21. Hunt MC, Tillander V, Alexson SEH. Regulation of peroxisomal lipid metabolism: the role of acyl-CoA and coenzyme A metabolizing enzymes. Biochimie. 2014; 98: 45-55.
22. Islinger M, Cardoso MJR, Schrader M. Be different-the diversity of peroxisomes in the animal kingdom. Biochim Biophys Acta. 2010; 1803: 881-97.
23. Pinheiro C, Longatto-Filho A, Azevedo-Silva J, et al. Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr. 2012; 44: 127-39.
24. Mathupala S, Parajuli P, Sloan A. Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study. Neurosurgery. 2004; 55: 1410-9.
25. Islinger M, Schrader M. Peroxisomes. Curr Biol. 2011; 21: R800-1.
26. Ribeiro D, Castro I, Fahimi HD, et al. Peroxisome morphology in pathology. Histol Histopathol. 2012; 27: 661-76.
27. Schrader M, Fahimi HD. The peroxisome: still a mysterious organelle. Histochem Cell Biol. 2008; 129: 421-40.
28. Litwin JA, Beier K, Völkl A, et al. Immunocytochemical investigation of catalase and peroxisomal lipid beta-oxidation enzymes in human hepatocellular tumors and liver cirrhosis. Virchows Arch. 1999; 435: 486-95.
29. Zecchini V, Madhu B, Russell R, et al. Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. EMBO J. 2014; 33: 1365-82.
30. Pinheiro C, Penna V, Morais-Santos F, et al. Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization. J Transl Med. 2014; 12: 118